Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT06065059 |
Title | Study to Evaluate TNG348 Alone and With a PARP Inhibitor in Patients With BRCA 1/2 Mutant or HRD+ Solid Tumors |
Recruitment | Recruiting |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Tango Therapeutics, Inc. |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
HealthONE | RECRUITING | Denver | Colorado | 80218 | United States | Details |
Mid Florida Cancer Centers | RECRUITING | Orange City | Florida | 32763 | United States | Details |
Florida Cancer Specialists | RECRUITING | Sarasota | Florida | 34232 | United States | Details |
Dana Farber Cancer Institute | RECRUITING | Boston | Massachusetts | 02215 | United States | Details |
New York University Langone Health | RECRUITING | New York | New York | 10016 | United States | Details |
Memorial Sloan Kettering Cancer Center | RECRUITING | New York | New York | 10065 | United States | Details |
The University of Texas MD Anderson Cancer Center | RECRUITING | Houston | Texas | 77030 | United States | Details |